To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCDC117TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
258 supporting clones for gene CCDC117 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK302925 testis .a 1 to 1031 5 to 1035 exact tiling clone,   1035/1035
(100 %)
1 diff
(100.0 %id)
DC403554 testis .a 1 to 459 5 to 464       464/464
(100 %)
2 diff
(99.6 %id)
DC402486 testis .b 1 to 236 6 to 241       241/241
(100 %)
1 diff
(99.6 %id)
AK289516 cerebellum .b 1 to 1472 2 to 1471 exact tiling clone,   1471/1471
(100 %)
2 diff
(99.9 %id)
NM_173510.2   .b 1 to 3983 2 to 3984 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 3984/3984
(100 %)
0 diff
(100 %id)
DA097943 cerebellum .b 1 to 499 2 to 499   capped   498/498
(100 %)
2 diff
(99.6 %id)
DC422752 uterus .b 2 to 332 1 to 331       331/331
(100 %)
3 diff
(99.1 %id)
DC402560 testis .b 23 to 329 1 to 307       307/307
(100 %)
1 diff
(99.7 %id)
DA192903 amygdala .b 32 to 548 2 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
DR003012 fetal brain .b 33 to 491 1 to 459       459/459
(100 %)
3 diff
(99.4 %id)
BC065549 Testis, embryonal carcinoma .b 38 to 1365 1 to 1328 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1328/1328
(100 %)
2 diff
(99.9 %id)
BC053874 Uterus, leiomyosarcoma .b 40 to 3983 1 to 3943 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 3943/3943
(100 %)
1 diff
(100.0 %id)
BI463616 testis .b 40 to 616 1 to 579       579/581
(99 %)
10 diff
(98.3 %id)
BF979730 testis .b 43 to 642 1 to 603       603/1014
(59 %)
17 diff
(98.4 %id)
BM470009 lymph, lymphoma, cell line .b 43 to 555 28 to 544       517/1410
(36 %)
29 diff
(98.0 %id)
CF135578 lymph .b 44 to 714 1 to 671       671/671
(100 %)
5 diff
(99.3 %id)
CB988603 Human Placenta, placenta .b 44 to 778 19 to 758       740/892
(82 %)
18 diff
(98.0 %id)
CF593611 Human Placenta, placenta .b 44 to 764 20 to 743       724/870
(83 %)
17 diff
(98.1 %id)
DA720348   .b 44 to 307 2 to 265   capped   264/264
(100 %)
0 diff
(100 %id)
BC040488 testis .b 45 to 3979 1 to 3935 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 3935/3935
(100 %)
5 diff
(99.9 %id)
DB072391 testis .b 46 to 499 2 to 455   capped   454/454
(100 %)
1 diff
(99.8 %id)
DB075356 testis .b 46 to 553 2 to 509   capped   508/508
(100 %)
1 diff
(99.9 %id)
DB453846 testis .b 48 to 543 1 to 496       496/496
(100 %)
2 diff
(99.6 %id)
TI_154164009   .b 48 to 945 74 to 959       886/933
(94 %)
29 diff
(96.9 %id)
BI908722 leukocyte .b 51 to 816 1 to 805       803/807
(99 %)
47 diff
(94.2 %id)
TI_57234644   .b 51 to 816 37 to 841       803/843
(95 %)
36 diff
(95.8 %id)
BG773625 choriocarcinoma, placenta .b 56 to 466 1 to 412       412/414
(99 %)
4 diff
(99.1 %id)
DA054120 cerebellum .b 58 to 499 2 to 443   capped   442/442
(100 %)
0 diff
(100 %id)
BI461203 testis .b 61 to 740 1 to 679       679/679
(100 %)
6 diff
(99.2 %id)
BU430845 lymph .b 62 to 412 1 to 350       350/361
(96 %)
7 diff
(98.1 %id)
DB450970.
matches multiple genes
testis .b 65 to 534 1 to 471     also hits gene bloyter 471/471
(100 %)
9 diff
(98.1 %id)
DB505392.
matches multiple genes
hypothalamus .b 65 to 521 1 to 457     also hits gene bloyter 457/457
(100 %)
4 diff
(99.2 %id)
TI_154152359   .b 69 to 614 80 to 625       546/546
(100 %)
17 diff
(96.9 %id)
AK091133 tongue, tumor tissue .b 74 to 3982 1 to 3905 L102P tiling clone, available from FLJ,   3905/3905
(100 %)
8 diff
(99.8 %id)
AX746797   .b 74 to 3982 1 to 3905 L102P     3905/3905
(100 %)
8 diff
(99.8 %id)
CF135709 lymph .b 74 to 588 1 to 515       515/515
(100 %)
20 diff
(96.2 %id)
DA435916 tongue, tumor tissue .b 75 to 655 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
BE731831 choriocarcinoma, placenta .b 75 to 939 1 to 862   available from MGC,   862/1014
(85 %)
43 diff
(95.8 %id)
BU506786 leiomyosarcoma, uterus .b 78 to 778 1 to 708       708/968
(73 %)
12 diff
(98.8 %id)
TI_154164236   .b 80 to 640 76 to 636       561/881
(63 %)
24 diff
(97.3 %id)
BX437471 thymus .b 94 to 905 1 to 810       810/810
(100 %)
2 diff
(99.8 %id)
DB290137 uterus .b 95 to 670 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA619010   .b 101 to 421 2 to 322   capped   321/321
(100 %)
0 diff
(100 %id)
CR987213 T-Lymphocytes .b 107 to 527 1 to 421       421/425
(99 %)
3 diff
(99.3 %id)
CF137452 lymph .b 110 to 380 8 to 278       271/278
(97 %)
7 diff
(97.5 %id)
BU429519 lymph .b 115 to 498 1 to 384       384/384
(100 %)
8 diff
(98.0 %id)
EL734787 mixed .b 176 to 798 1 to 623       623/623
(100 %)
0 diff
(100 %id)
TI_1948236321   .b 176 to 398 136 to 358       223/251
(88 %)
6 diff
(97.7 %id)
TI_1948236322   .b 176 to 284 129 to 237       109/136
(80 %)
7 diff
(94.9 %id)
TI_1948236324   .b 192 to 1014 952 to 127       826/1257
(65 %)
15 diff
(98.9 %id)
DA326691 hippocampus .b 198 to 757 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BG771811 testis .b 244 to 1001 1 to 761       761/763
(99 %)
15 diff
(98.1 %id)
AW999310 breast_normal .b 292 to 597 1 to 306       306/306
(100 %)
0 diff
(100 %id)
DB072522 testis .b 339 to 877 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
BI256293 cervical carcinoma cell line, cervix .b 382 to 1156 1 to 782       782/844
(92 %)
24 diff
(97.2 %id)
AI373370 Kidney .b 393 to 781 396 to 8       392/396
(98 %)
0 diff
(100 %id)
CD643560 Embryonic Stem cells .b 403 to 1162 12 to 767       756/816
(92 %)
7 diff
(99.2 %id)
DB095411 testis .b 413 to 715 252 to 554   capped   303/553
(54 %)
6 diff
(99.0 %id)
BI032755 nervous_normal .b 441 to 963 1 to 523       523/523
(100 %)
13 diff
(97.6 %id)
TI_1948235850   .b 453 to 1014 1177 to 604     Submitted on the opposite strand 574/1235
(46 %)
30 diff
(97.6 %id)
TI_1948235621   .b 454 to 1014 1161 to 602     Submitted on the opposite strand 560/1207
(46 %)
33 diff
(97.3 %id)
AW504186 lymph .b 458 to 931 8 to 481       474/481
(98 %)
6 diff
(98.8 %id)
TI_154160291   .b 458 to 1010 86 to 638       553/554
(99 %)
2 diff
(99.7 %id)
TI_1948236087   .b 463 to 1014 1154 to 602     Submitted on the opposite strand 553/1209
(45 %)
24 diff
(98.1 %id)
W27551 eye, retina .b 481 to 970 23 to 509       487/572
(85 %)
11 diff
(98.1 %id)
BG012866 placenta_normal .b 492 to 750 265 to 7       259/277
(93 %)
0 diff
(100 %id)
AA019907 eye, retina .b 510 to 762 1 to 252       252/252
(100 %)
1 diff
(99.7 %id)
BE814840 breast_normal .b 553 to 887 16 to 350       335/350
(95 %)
7 diff
(98.0 %id)
CN392176 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 580 to 1231 1 to 652       652/652
(100 %)
2 diff
(99.7 %id)
AL597328   .b 588 to 1187 1 to 601       601/601
(100 %)
7 diff
(98.9 %id)
AW070234 pooled .b 597 to 1052 457 to 2       456/457
(99 %)
0 diff
(100 %id)
TI_1948236086   .b 646 to 1014 981 to 615     Submitted on the opposite strand 367/1348
(27 %)
31 diff
(97.8 %id)
TI_1948235849   .b 692 to 1014 938 to 614     Submitted on the opposite strand 325/1430
(22 %)
14 diff
(99.1 %id)
CD652067 Embryonic Stem cells .b 721 to 1515 7 to 801       795/809
(98 %)
15 diff
(98.2 %id)
TI_1948236323   .b 811 to 1014 329 to 126       204/231
(88 %)
0 diff
(100 %id)
DB146059 thymus .b 867 to 1415 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
CN392175 embryonic stem cells, cell lines H1, H7, andH9 .b 872 to 1491 1 to 620       620/620
(100 %)
0 diff
(100 %id)
AA912733 pooled .b 880 to 1052 173 to 2       172/173
(99 %)
0 diff
(100 %id)
BU532169 mixed (pool of 40 RNAs) .b 885 to 1269 1 to 385       385/420
(91 %)
5 diff
(98.9 %id)
CF137787 lymph .b 896 to 1281 8 to 393       386/393
(98 %)
5 diff
(98.8 %id)
TI_154167412   .b 896 to 1371 81 to 556       476/478
(99 %)
3 diff
(99.4 %id)
BX478163   .b 969 to 1566 1 to 600       600/600
(100 %)
5 diff
(99.2 %id)
BF332121 breast .b 1020 to 1438 422 to 6       417/424
(98 %)
0 diff
(100 %id)
BF351926 head_neck .b 1020 to 1291 24 to 295       272/295
(92 %)
11 diff
(96.3 %id)
BF332092 breast .b 1032 to 1428 1 to 395       395/395
(100 %)
5 diff
(98.8 %id)
BF351823 head_neck .b 1032 to 1435 411 to 8       404/411
(98 %)
0 diff
(100 %id)
BM829216 Ascites, stomach .b 1043 to 1743 1 to 701       701/701
(100 %)
0 diff
(100 %id)
TI_57174794   .b 1050 to 1378 30 to 356   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 327/356
(91 %)
6 diff
(98.4 %id)
BE173104 head_neck .b 1051 to 1428 1 to 379       379/379
(100 %)
4 diff
(99.0 %id)
AW058515 Kidney .b 1051 to 1591 541 to 1       541/541
(100 %)
1 diff
(99.9 %id)
BI827356 brain, medulla .b 1053 to 1378 1 to 324   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 324/324
(100 %)
3 diff
(99.1 %id)
BI463727 testis .b 1087 to 1817 1 to 739       739/743
(99 %)
21 diff
(97.2 %id)
FN116662 breast carcinoma .b 1103 to 1228 123 to 1     Submitted on the opposite strand 123/123
(100 %)
3 diff
(97.6 %id)
DA738012   .b 1112 to 1878 2 to 770   capped   769/773
(99 %)
15 diff
(98.1 %id)
DA391125 thalamus .b 1121 to 1703 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DB132857 thymus .b 1141 to 1570 2 to 431   capped   430/430
(100 %)
1 diff
(99.8 %id)
BG703693 brain, hippocampus .b 1201 to 1892 1 to 700       700/764
(91 %)
19 diff
(97.6 %id)
BX956471   .b 1337 to 1963 1 to 627       627/627
(100 %)
1 diff
(99.9 %id)
CN392177 embryonic stem cells, cell lines H1, H7, andH9 .b 1346 to 1981 1 to 637       637/637
(100 %)
2 diff
(99.7 %id)
BX478425   .b 1451 to 2070 1 to 620       620/620
(100 %)
0 diff
(100 %id)
DA573215 whole embryo, mainly body .b 1557 to 2346 2 to 794   capped   793/793
(100 %)
8 diff
(99.0 %id)
DA765538 tongue .b 1600 to 2183 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
DA651467   .b 1638 to 2164 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
BQ228950 embryonal carcinoma, cell line, testis .b 1690 to 2573 1 to 883       883/883
(100 %)
5 diff
(99.5 %id)
AA376658 small intestine .b 1734 to 2052 1 to 320       320/320
(100 %)
1 diff
(99.7 %id)
AL601098   .b 1737 to 2494 1 to 758       758/758
(100 %)
7 diff
(99.1 %id)
BF576633 muscle (skeletal) .b 1737 to 2025 1 to 297       297/299
(99 %)
17 diff
(94.4 %id)
AL601110   .b 1738 to 2342 1 to 604       604/604
(100 %)
6 diff
(99.1 %id)
BE005161 breast_normal .b 1758 to 2195 460 to 23     Submitted on the opposite strand 438/462
(94 %)
0 diff
(100 %id)
BM451436 eye, retinoblastoma .b 1845 to 2659 1 to 838       838/1131
(74 %)
29 diff
(97.5 %id)
AA749290 germinal center B cell .b 1888 to 2272 1 to 384     Submitted on the opposite strand 384/384
(100 %)
3 diff
(99.3 %id)
AA836102 germinal center B cell .b 1928 to 2371 1 to 439       439/439
(100 %)
9 diff
(98.0 %id)
DA272821 caudate nucleus .b 1980 to 2516 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BQ639669 eye, retina .b 1980 to 2591 1 to 612       612/612
(100 %)
0 diff
(100 %id)
CX760627 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1984 to 2557 1 to 574     Submitted on the opposite strand 574/574
(100 %)
0 diff
(100 %id)
TI_149298256   .b 1998 to 2998 1066 to 80   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 987/992
(99 %)
21 diff
(97.9 %id)
DA521099 brain .b 2031 to 2598 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
AW794825 uterus .b 2044 to 2226 183 to 1       183/183
(100 %)
0 diff
(100 %id)
AV650462 corresponding non cancerous liver tissue .b 2081 to 2561 1 to 479     Submitted on the opposite strand 479/666
(71 %)
8 diff
(98.8 %id)
AA093790   .b 2085 to 2394 1 to 295       295/311
(94 %)
23 diff
(92.7 %id)
AV650466 corresponding non cancerous liver tissue .b 2090 to 2712 10 to 619     Submitted on the opposite strand 610/702
(86 %)
5 diff
(99.3 %id)
AA082768   .b 2112 to 2628 1 to 516       516/522
(98 %)
2 diff
(99.7 %id)
AA382511 testis .b 2137 to 2421 1 to 287       287/289
(99 %)
6 diff
(98.0 %id)
AW960363   .b 2143 to 2706 1 to 565       565/566
(99 %)
13 diff
(97.8 %id)
AA313750 colon .b 2154 to 2564 1 to 411       411/411
(100 %)
0 diff
(100 %id)
BE905724 epithelioid carcinoma, Pancreas .b 2159 to 2865 1 to 713       713/1080
(66 %)
36 diff
(96.7 %id)
FN146139 breast carcinoma .b 2165 to 2238 1 to 75       75/75
(100 %)
3 diff
(96.0 %id)
FN120566 breast carcinoma .b 2166 to 2238 1 to 72       72/72
(100 %)
3 diff
(95.9 %id)
AK092636 Prostate .b 2181 to 3989 1 to 1805   available from FLJ,   1805/1805
(100 %)
4 diff
(99.8 %id)
DA873714 Prostate .b 2182 to 2751 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
Z44053 brain, total brain .b 2201 to 2509 1 to 310       310/310
(100 %)
6 diff
(98.1 %id)
R21272 whole brain .b 2203 to 2626 1 to 441     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 441/444
(99 %)
24 diff
(94.6 %id)
BJ994072 hepatoblastoma .b 2222 to 2821 1 to 600       600/600
(100 %)
0 diff
(100 %id)
DB313390 tongue, tumor tissue .b 3437 to 3982 543 to 1       543/543
(100 %)
6 diff
(98.9 %id)
DB330047 Prostate .b 3449 to 3990 538 to 1       538/538
(100 %)
3 diff
(99.5 %id)
AA101114   .b 3473 to 3984 510 to 1       510/510
(100 %)
3 diff
(99.5 %id)
DB370625   .b 3531 to 3983 454 to 1       454/458
(99 %)
6 diff
(98.7 %id)
DB360378 whole embryo, mainly body .b 3548 to 3979 432 to 1       432/433
(99 %)
1 diff
(99.8 %id)
BJ994073 hepatoblastoma .b 3583 to 3947 363 to 1       363/363
(100 %)
1 diff
(99.8 %id)
R45362 whole brain .b 3677 to 3983 321 to 11   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 311/311
(100 %)
4 diff
(98.8 %id)
Z41665 brain, total brain .b 3716 to 3983 268 to 1       268/268
(100 %)
0 diff
(100 %id)
AK295140 brain .c 1 to 1137 1 to 1137 exact tiling clone,   1137/1137
(100 %)
1 diff
(100.0 %id)
DC324931 brain .c 1 to 595 1 to 595       595/595
(100 %)
0 diff
(100 %id)
CF993940 Human Placenta, placenta .d 1 to 515 31 to 545   tiling clone,   517/563
(91 %)
9 diff
(98.5 %id)
DB087275 testis .d 433 to 987 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
AK302798 testis .d 439 to 1523 11 to 1095 exact tiling clone,   1085/1085
(100 %)
1 diff
(100.0 %id)
DB084172 testis .d 439 to 991 11 to 563   capped   553/553
(100 %)
0 diff
(100 %id)
DB084448 testis .d 480 to 1024 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
AK127794 brain .e-u 1 to 3211 2 to 3217   tiling clone, available from FLJ,   3217/3217
(100 %)
13 diff
(99.6 %id)
DA808163 brain .e-u 1 to 563 2 to 569   capped   568/568
(100 %)
8 diff
(98.6 %id)
BQ026297 placenta .e-u 324 to 826 521 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 503/511
(98 %)
0 diff
(100 %id)
AI758333 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .e-u 532 to 827 296 to 1       296/296
(100 %)
1 diff
(99.7 %id)
DA727999   .e-u 2449 to 3054 2 to 607   capped   606/609
(99 %)
2 diff
(99.7 %id)
AW902541 nervous_normal .e-u 2457 to 2914 1 to 457       457/457
(100 %)
2 diff
(99.6 %id)
AA150232 uterus .e-u 2483 to 2847 1 to 369   fully sequenced,   369/369
(100 %)
5 diff
(98.7 %id)
BF693621 muscle (skeletal) .e-u 2561 to 3183 1 to 635       635/831
(76 %)
24 diff
(97.2 %id)
BF693960 muscle (skeletal) .e-u 2562 to 3206 1 to 638       638/817
(78 %)
29 diff
(96.5 %id)
AI680900 carcinoid, lung .e-u 2563 to 3001 12 to 450     Submitted on the opposite strand 439/450
(97 %)
6 diff
(98.7 %id)
CB850689 lung, Primary Lung Cystic Fibrosis EpithelialCells .e-u 2567 to 3211 663 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 645/645
(100 %)
0 diff
(100 %id)
BE702344 nervous_normal .e-u 2570 to 2988 420 to 1       420/420
(100 %)
8 diff
(98.1 %id)
BM846250 myeloma .e-u 2632 to 3234 1 to 603       603/603
(100 %)
0 diff
(100 %id)
AW902542 nervous_normal .e-u 2683 to 3116 434 to 1       434/434
(100 %)
0 diff
(100 %id)
DB327267 brain .e-u 2688 to 3211 524 to 1       524/524
(100 %)
1 diff
(99.9 %id)
BE539451 cervix .e-u 2692 to 3305 1 to 616       616/814
(75 %)
17 diff
(98.0 %id)
EL948230 eyeball .e-u 2703 to 3252 1 to 550       550/550
(100 %)
4 diff
(99.3 %id)
AW902625 nervous_normal .e-u 2735 to 3110 376 to 1       376/376
(100 %)
2 diff
(99.5 %id)
AW902616 nervous_normal .e-u 2739 to 3116 377 to 1       377/377
(100 %)
2 diff
(99.5 %id)
BF697354 brain, primitive neuroectoderm .e-u 2763 to 3481 1 to 705       705/803
(87 %)
35 diff
(95.7 %id)
BF242137 bone marrow, from acute myelogenous leukemia .e-u 2764 to 3458 1 to 689       689/794
(86 %)
32 diff
(96.0 %id)
AA758905   .e-u 2788 to 3211 434 to 11   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 424/424
(100 %)
1 diff
(99.8 %id)
AA152290 uterus .e-u 2817 to 3211 398 to 1   fully sequenced,   398/398
(100 %)
2 diff
(99.5 %id)
BF795360 lymph, lymphoma, cell line .e-u 2883 to 3679 1 to 797       797/944
(84 %)
31 diff
(96.8 %id)
BF107104 placenta .e-u 2907 to 3455 1 to 547       547/801
(68 %)
14 diff
(98.3 %id)
BF692627 melanotic melanoma, high MDR, skin .e-u 2917 to 3455 1 to 535       535/535
(100 %)
4 diff
(99.3 %id)
BE539873 cervix .e-u 2918 to 3647 1 to 715       715/750
(95 %)
18 diff
(97.6 %id)
BE866565 bladder, carcinoma, cell line .e-u 2923 to 3163 1 to 247       247/299
(82 %)
8 diff
(97.4 %id)
AW631003 2 pooled high-grade transitional celltumors, genitourinary tract .e-u 2929 to 3353 1 to 425       425/425
(100 %)
1 diff
(99.8 %id)
BG616409 embryonal carcinoma, testis .e-u 2949 to 3700 1 to 756       756/758
(99 %)
9 diff
(98.9 %id)
T35196 prostate gland .e-u 2951 to 3248 1 to 302       302/302
(100 %)
4 diff
(98.7 %id)
BP871276 embryonal kidney .e-u 2974 to 3307 1 to 333       333/333
(100 %)
1 diff
(99.7 %id)
CB270144 adipose .e-u 2982 to 3600 8 to 625       618/632
(97 %)
7 diff
(98.9 %id)
BG537305 lung .e-u 2985 to 3670 1 to 702       702/725
(96 %)
42 diff
(94.3 %id)
CF144362 CNCAP(3)T-225 cell line, Prostate .e-u 3001 to 3502 1 to 502       502/502
(100 %)
5 diff
(99.1 %id)
CF144442 CNCAP(3)T-225 cell line, Prostate .e-u 3001 to 3558 1 to 558       558/558
(100 %)
6 diff
(99.0 %id)
AA131718 uterus .e-u 3006 to 3278 1 to 275       275/275
(100 %)
2 diff
(99.3 %id)
TI_154176397   .e-u 3008 to 3621 94 to 702       609/855
(71 %)
13 diff
(98.5 %id)
TI_154176493   .e-u 3008 to 3682 80 to 772       693/1085
(63 %)
31 diff
(97.2 %id)
H13385 whole brain .e-u 3018 to 3413 1 to 411       411/413
(99 %)
22 diff
(94.7 %id)
Z42470 brain, total brain .e-u 3020 to 3254 6 to 241       236/241
(97 %)
5 diff
(98.0 %id)
AW798211 uterus .e-u 3025 to 3211 1 to 185       185/200
(92 %)
6 diff
(97.0 %id)
FN050025 breast carcinoma .e-u 3033 to 3134 102 to 1     Submitted on the opposite strand 102/102
(100 %)
1 diff
(99.1 %id)
AL135583 melanoma (MeWo cell line) .e-u 3043 to 3551 1 to 508       508/508
(100 %)
2 diff
(99.7 %id)
BG289974 bladder, transitional cell papilloma, cell line .e-u 3087 to 3804 14 to 730       717/929
(77 %)
10 diff
(99.0 %id)
AA422115 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3089 to 3275 1 to 187   fully sequenced,   187/187
(100 %)
0 diff
(100 %id)
AA426139 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3089 to 3346 1 to 258   fully sequenced,   258/258
(100 %)
0 diff
(100 %id)
AA453890 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3089 to 3549 1 to 461   fully sequenced,   461/461
(100 %)
0 diff
(100 %id)
BY994212   .e-u 3101 to 3778 10 to 687   tiling clone,   678/687
(98 %)
8 diff
(98.9 %id)
BF665367 brain, primitive neuroectoderm .e-u 3104 to 3807 1 to 694       694/900
(77 %)
23 diff
(97.5 %id)
EC528366 Prostate .e-u 3119 to 3210 90 to 3       88/90
(97 %)
0 diff
(100 %id)
AI263798 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3122 to 3562 443 to 1       443/443
(100 %)
4 diff
(99.1 %id)
AI417141 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3122 to 3561 440 to 1       440/440
(100 %)
0 diff
(100 %id)
AI223864 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3123 to 3562 440 to 1       440/440
(100 %)
0 diff
(100 %id)
CN392174 embryonic stem cells, DMSO-treated H9 cellline .e-u 3143 to 3666 1 to 524       524/524
(100 %)
0 diff
(100 %id)
AI800697 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3143 to 3562 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AA300364 testis .e-u 3144 to 3495 1 to 350       350/350
(100 %)
3 diff
(99.2 %id)
AW959461   .e-u 3145 to 3739 1 to 603       603/643
(93 %)
51 diff
(92.1 %id)
BI089798 cervix .e-u 3162 to 3867 1 to 725 F2Q Y3G V4*     725/818
(88 %)
12 diff
(98.6 %id)
BE538082 cervix .e-u 3196 to 3826 1 to 630 C68V V69*     630/630
(100 %)
7 diff
(98.9 %id)
BF574294 muscle (skeletal) .e-u 3243 to 3877 1 to 630 exact     630/876
(71 %)
13 diff
(98.6 %id)
AA411231 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3245 to 3562 317 to 1   fully sequenced,   317/317
(100 %)
1 diff
(99.7 %id)
BF126295 Liver .e-u 3275 to 3869 1 to 586 W7G T8L L9Y S10L S11L ...     586/687
(85 %)
19 diff
(97.3 %id)
AW954286   .e-u 3293 to 3709 1 to 418       418/421
(99 %)
3 diff
(99.3 %id)
AA424919 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3316 to 3562 247 to 1   fully sequenced,   247/247
(100 %)
0 diff
(100 %id)
AA453804 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3337 to 3562 226 to 1   fully sequenced,   226/226
(100 %)
0 diff
(100 %id)
BQ068120 brain .e-u 3392 to 4027 1 to 646 exact     646/1369
(47 %)
24 diff
(98.3 %id)
BQ428730 testis .e-u 3482 to 4144 1 to 665 exact AAA   665/725
(91 %)
7 diff
(99.1 %id)
BX107697 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3508 to 4103 1 to 596 exact     596/596
(100 %)
1 diff
(99.9 %id)
AA625187 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3513 to 3917 9 to 413 F6P     405/413
(98 %)
6 diff
(98.6 %id)
AA904708 pooled .e-u 3534 to 3928 392 to 2       391/392
(99 %)
0 diff
(100 %id)
AA418230 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3545 to 3902 1 to 358   fully sequenced,   358/358
(100 %)
0 diff
(100 %id)
BE708295 head_neck .e-u 3566 to 3740 1 to 173       173/174
(99 %)
7 diff
(96.0 %id)
BG257004 embryonal carcinoma, cell line, testis .e-u 3588 to 4192 1 to 602       602/649
(92 %)
17 diff
(97.4 %id)
BF060776 pooled .e-u 3614 to 4196 582 to 1       582/582
(100 %)
2 diff
(99.7 %id)
AI970427 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .e-u 3618 to 4095 553 to 77       477/553
(86 %)
0 diff
(100 %id)
AI656823 pooled germ cell tumors .e-u 3653 to 4192 551 to 10       542/551
(98 %)
0 diff
(100 %id)
AI742396 pooled .e-u 3661 to 4195 534 to 1       534/534
(100 %)
1 diff
(99.9 %id)
AW237075 pooled germ cell tumors .e-u 3661 to 4187 537 to 10       528/537
(98 %)
0 diff
(100 %id)
FN056046 breast carcinoma .e-u 3669 to 3753 1 to 85       85/86
(98 %)
4 diff
(95.4 %id)
BM700999 eye, human retina .e-u 3687 to 3864 1 to 179   fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 179/179
(100 %)
4 diff
(97.8 %id)
AI990631 pooled germ cell tumors .e-u 3688 to 4196 511 to 1       511/511
(100 %)
3 diff
(99.5 %id)
AW873502 pooled .e-u 3690 to 4197 510 to 5       506/510
(99 %)
0 diff
(100 %id)
AI638335 pooled germ cell tumors .e-u 3693 to 4197 508 to 3       506/508
(99 %)
0 diff
(100 %id)
BQ023223 placenta .e-u 3723 to 4196 492 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 474/474
(100 %)
8 diff
(98.4 %id)
AI093952 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3737 to 4196 460 to 1   tiling clone,   460/460
(100 %)
0 diff
(100 %id)
AI275588 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3741 to 4192 456 to 5       452/456
(99 %)
0 diff
(100 %id)
AI991570 pooled germ cell tumors .e-u 3755 to 4196 444 to 1       444/444
(100 %)
2 diff
(99.6 %id)
BE221569 malignant melanoma, metastatic to lymphnode, skin .e-u 3755 to 4196 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
AI168645 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3756 to 4196 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AI150145   .e-u 3763 to 4192 432 to 6       427/432
(98 %)
0 diff
(100 %id)
AI431506 lymph node, lymphoma, follicular mixed small and largecell .e-u 3763 to 4192 431 to 1       431/431
(100 %)
1 diff
(99.8 %id)
AI825352 pooled germ cell tumors .e-u 3766 to 4197 442 to 10       433/442
(97 %)
0 diff
(100 %id)
AI797514 pooled .e-u 3773 to 4196 425 to 1       425/425
(100 %)
19 diff
(95.6 %id)
AW589724 pooled germ cell tumors .e-u 3781 to 4197 419 to 2       418/419
(99 %)
0 diff
(100 %id)
AA741277 germinal center B cell .e-u 3785 to 4196 422 to 11   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 412/412
(100 %)
0 diff
(100 %id)
AI924204 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .e-u 3790 to 4202 414 to 2   tiling clone,   413/414
(99 %)
0 diff
(100 %id)
BF447125 Prostate .e-u 3798 to 4196 401 to 1       401/401
(100 %)
1 diff
(99.8 %id)
AW592420 pooled .e-u 3801 to 4197 402 to 5       398/402
(99 %)
0 diff
(100 %id)
AA905158 pooled .e-u 3808 to 4196 400 to 11   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 390/390
(100 %)
8 diff
(98.0 %id)
BQ023041 placenta .e-u 3819 to 4196 396 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 378/378
(100 %)
4 diff
(99.0 %id)
AW627700 2 pooled high-grade transitional celltumors, genitourinary tract .e-u 3821 to 4197 378 to 5       374/378
(98 %)
0 diff
(100 %id)
BM672330 eye, human retina .e-u 3834 to 4196 382 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 364/364
(100 %)
3 diff
(99.2 %id)
AA769817   .e-u 3839 to 4196 388 to 30   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 359/359
(100 %)
1 diff
(99.8 %id)
AA811505 germinal center B cell .e-u 3859 to 4132 275 to 1       275/275
(100 %)
2 diff
(99.3 %id)
AA418083 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 3872 to 4196 325 to 1   fully sequenced,   325/325
(100 %)
0 diff
(100 %id)
AI127559 uterus .e-u 3872 to 4196 325 to 1       325/325
(100 %)
1 diff
(99.7 %id)
BQ023068 placenta .e-u 3885 to 4196 330 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 312/319
(97 %)
0 diff
(100 %id)
BU198059 ectopic and normal uterine endometrium .e-u 3892 to 4196 1 to 302   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 302/302
(100 %)
5 diff
(98.4 %id)
AA131634 uterus .e-u 3896 to 4196 302 to 2       301/306
(98 %)
0 diff
(100 %id)
AA969156 pooled .e-u 3897 to 4196 314 to 15   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 300/300
(100 %)
0 diff
(100 %id)
H06049.
matches multiple genes
whole brain .e-u 3906 to 4196 311 to 20   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base), also hits gene C7orf41 292/314
(92 %)
12 diff
(96.2 %id)
AA770192   .e-u 3912 to 4196 314 to 30   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 285/285
(100 %)
0 diff
(100 %id)
EH314843   .e-u 3966 to 4022 1 to 57       57/57
(100 %)
2 diff
(96.5 %id)
AI868861 Prostate .e-u 3974 to 4185 236 to 25   AAA   212/223
(95 %)
0 diff
(100 %id)
BE885731 leiomyosarcoma, uterus .e-u 3981 to 4187 1 to 212       212/212
(100 %)
5 diff
(97.7 %id)
T36015 testis .e-u 3983 to 4192 210 to 1       210/211
(99 %)
0 diff
(100 %id)
AI434398 lymph node, lymphoma, follicular mixed small and largecell .e-u 4001 to 4197 195 to 2       194/195
(99 %)
0 diff
(100 %id)
AW050658 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e-u 4014 to 4196 183 to 1       183/183
(100 %)
2 diff
(99.0 %id)
FN046443 breast carcinoma .e-u 4114 to 4177 1 to 66       66/67
(98 %)
3 diff
(95.6 %id)
DB077525 testis .f 1 to 562 2 to 563   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
AV650620 corresponding non cancerous liver tissue Gene CCDC117, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
CR456461   Gene CCDC117, variant not shown         This clone was ignored    
BU429695 lymph Gene CCDC117, variant not shown         This clone was ignored    
CU013300 Synthetic constructs Gene CCDC117, variant not shown         This clone was ignored    
CU013012 Synthetic constructs Gene CCDC117, variant not shown         This clone was ignored    
DB219748 trachea Gene CCDC117, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C